Pathogen Adherence to Carbohydrate Database (PACDB)

PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.

Database Last Updated
Pathogen Adherence to Carbohydrate Database (PACDB) June 1, 2016
Species Pathogen Adherence Molecule Ligand Name Ligand Feature Target Source ▲ Glycan Sequence Binding PubMed ID
Unknown
Gb4 (Globoside; Globotetraose; P antigen)
Oligoglycosylceramides
Human colon adenocarcinoma cells (WiDr )
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
I-active Gal2-lactoisooctaosylceramide
Oligoglycosylceramides
Human colon adenocarcinoma cells (WiDr )
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
NeuGc3-nLc6Cer
Sialoglycosphingolipids
Human colon adenocarcinoma cells (WiDr )
NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
Lactosylceramide (Lactocerebroside)
Diosylceramides
Human colon adenocarcinoma cells (WiDr )
Gal(b1-4)Glc(b1-1)Cer
Binding
Unknown
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
Oligoglycosylceramides
Human colon adenocarcinoma cells (WiDr )
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
Oligoglycosylceramides
Human colon adenocarcinoma cells (WiDr )
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
20K-fimbriae
GlcNAc sequence
Saccharides
Human colon carcinoma Caco-2 cell line
GlcNAc
Binding
Unknown
Galactosylceramide (or derivative)
Monoglycosylceramides
Human colon epithelial HT29 cells
Gal(b1-1)Cer
Binding
Toxin A
unnamed ligand
Oligosaccharides
Human colonic cells
Gal(a1-3)Gal(b1-4)GlcNAc
Binding
C-terminal domain of toxin A molecules
unnamed ligand
Oligosaccharides
Human colonic cells
Gal(a1-3)Gal(b1-4)GlcNAc
Binding
Displaying entries 291 - 300 of 1840 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01